APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sleeping Pills (Prescription Drugs)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Sleeping Pills (Prescription Drugs) Market Outlook and Growth Opportunities 2026

26 December 2025191 pages

Choose your research edition.

Industry ResearchSleeping Pills (Prescription Drugs) Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Sleeping Pills (Prescription Drugs) Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Sleeping Pills (Prescription Drugs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sleeping Pills (Prescription Drugs) Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Sleeping Pills (Prescription Drugs) Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Sleeping Pills (Prescription Drugs) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sleeping Pills (Prescription Drugs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sleeping Pills (Prescription Drugs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sleeping Pills (Prescription Drugs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sleeping Pills (Prescription Drugs) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sleeping Pills (Prescription Drugs) market include Abbott Laboratories, Takeda Pharmaceutical, Sanofi, Hayao, Cayman Chemical, Aurobindo Pharma, Apotex, Ambitropin and Allegiant Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sleeping Pills (Prescription Drugs) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sleeping Pills (Prescription Drugs) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sleeping Pills (Prescription Drugs) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sleeping Pills (Prescription Drugs) market size, projected growth trends, production technologies, key applications, and end-use industries.

Sleeping Pills (Prescription Drugs) Segment by Company

Abbott Laboratories

Takeda Pharmaceutical

Sanofi

Hayao

Cayman Chemical

Aurobindo Pharma

Apotex

Ambitropin

Allegiant Health

Actellon Pharmaceuticals

Sleeping Pills (Prescription Drugs) Segment by Type

Adapin (doxepin)

Ativan (lorazepam)

Ramelteon (Rozerem)

Eszopiclone (Lunesta)

Zolpidem

Sleeping Pills (Prescription Drugs) Segment by Application

Hospital Pharmacy

Retail Pharmacy

Sleeping Pills (Prescription Drugs) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Sleeping Pills (Prescription Drugs) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sleeping Pills (Prescription Drugs) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sleeping Pills (Prescription Drugs) significant trends, drivers, influence factors in global and regions.

6. To analyze Sleeping Pills (Prescription Drugs) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sleeping Pills (Prescription Drugs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sleeping Pills (Prescription Drugs) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sleeping Pills (Prescription Drugs).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sleeping Pills (Prescription Drugs) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sleeping Pills (Prescription Drugs) industry.

Chapter 3: Detailed analysis of Sleeping Pills (Prescription Drugs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sleeping Pills (Prescription Drugs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sleeping Pills (Prescription Drugs) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sleeping Pills (Prescription Drugs) Industry Trends Table 2. Sleeping Pills (Prescription Drugs) Industry Drivers Table 3. Sleeping Pills (Prescription Drugs) Industry Opportunities and Challenges Table 4. Sleeping Pills (Prescription Drugs) Industry Restraints Table 5. Global Sleeping Pills (Prescription Drugs) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sleeping Pills (Prescription Drugs) Revenue Share by Company (2021-2026) Table 7. Global Sleeping Pills (Prescription Drugs) Sales Volume by Company (M Units) & (2021-2026) Table 8. Global Sleeping Pills (Prescription Drugs) Sales Volume Share by Company (2021-2026) Table 9. Global Sleeping Pills (Prescription Drugs) Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Sleeping Pills (Prescription Drugs) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sleeping Pills (Prescription Drugs) Key Company Manufacturing Base & Headquarters Table 12. Global Sleeping Pills (Prescription Drugs) Company, Product Type & Application Table 13. Global Sleeping Pills (Prescription Drugs) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sleeping Pills (Prescription Drugs) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Adapin (doxepin) Table 18. Significant Companies of Ativan (lorazepam) Table 19. Significant Companies of Ramelteon (Rozerem) Table 20. Significant Companies of Eszopiclone (Lunesta) Table 21. Significant Companies of Zolpidem Table 22. Global Sleeping Pills (Prescription Drugs) Sales Volume by Type 2021 VS 2025 VS 2032 (M Units) Table 23. Global Sleeping Pills (Prescription Drugs) Sales Volume by Type (2021-2026) & (M Units) Table 24. Global Sleeping Pills (Prescription Drugs) Sales Volume by Type (2027-2032) & (M Units) Table 25. Global Sleeping Pills (Prescription Drugs) Sales Volume Share by Type (2021-2026) Table 26. Global Sleeping Pills (Prescription Drugs) Sales Volume Share by Type (2027-2032) Table 27. Global Sleeping Pills (Prescription Drugs) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Sleeping Pills (Prescription Drugs) Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Sleeping Pills (Prescription Drugs) Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Sleeping Pills (Prescription Drugs) Sales Value Share by Type (2021-2026) Table 31. Global Sleeping Pills (Prescription Drugs) Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospital Pharmacy Table 33. Significant Companies of Retail Pharmacy Table 34. Global Sleeping Pills (Prescription Drugs) Sales Volume by Application 2021 VS 2025 VS 2032 (M Units) Table 35. Global Sleeping Pills (Prescription Drugs) Sales Volume by Application (2021-2026) & (M Units) Table 36. Global Sleeping Pills (Prescription Drugs) Sales Volume by Application (2027-2032) & (M Units) Table 37. Global Sleeping Pills (Prescription Drugs) Sales Volume Share by Application (2021-2026) Table 38. Global Sleeping Pills (Prescription Drugs) Sales Volume Share by Application (2027-2032) Table 39. Global Sleeping Pills (Prescription Drugs) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Sleeping Pills (Prescription Drugs) Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Sleeping Pills (Prescription Drugs) Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Sleeping Pills (Prescription Drugs) Sales Value Share by Application (2021-2026) Table 43. Global Sleeping Pills (Prescription Drugs) Sales Value Share by Application (2027-2032) Table 44. Global Sleeping Pills (Prescription Drugs) Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 45. Global Sleeping Pills (Prescription Drugs) Sales by Region (2021-2026) & (M Units) Table 46. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Region (2021-2026) Table 47. Global Sleeping Pills (Prescription Drugs) Sales by Region (2027-2032) & (M Units) Table 48. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Region (2027-2032) Table 49. Global Sleeping Pills (Prescription Drugs) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Sleeping Pills (Prescription Drugs) Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Sleeping Pills (Prescription Drugs) Sales Value Share by Region (2021-2026) Table 52. Global Sleeping Pills (Prescription Drugs) Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Sleeping Pills (Prescription Drugs) Sales Value Share by Region (2027-2032) Table 54. Global Sleeping Pills (Prescription Drugs) Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Sleeping Pills (Prescription Drugs) Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Sleeping Pills (Prescription Drugs) Sales by Country: 2021 VS 2025 VS 2032 (M Units) Table 57. Global Sleeping Pills (Prescription Drugs) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Sleeping Pills (Prescription Drugs) Sales by Country (2021-2026) & (M Units) Table 59. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Country (2021-2026) Table 60. Global Sleeping Pills (Prescription Drugs) Sales by Country (2027-2032) & (M Units) Table 61. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Country (2027-2032) Table 62. Global Sleeping Pills (Prescription Drugs) Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Sleeping Pills (Prescription Drugs) Sales Value Market Share by Country (2021-2026) Table 64. Global Sleeping Pills (Prescription Drugs) Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Sleeping Pills (Prescription Drugs) Sales Value Market Share by Country (2027-2032) Table 66. Abbott Laboratories Company Information Table 67. Abbott Laboratories Business Overview Table 68. Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Abbott Laboratories Sleeping Pills (Prescription Drugs) Product Portfolio Table 70. Abbott Laboratories Recent Development Table 71. Takeda Pharmaceutical Company Information Table 72. Takeda Pharmaceutical Business Overview Table 73. Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Product Portfolio Table 75. Takeda Pharmaceutical Recent Development Table 76. Sanofi Company Information Table 77. Sanofi Business Overview Table 78. Sanofi Sleeping Pills (Prescription Drugs) Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sanofi Sleeping Pills (Prescription Drugs) Product Portfolio Table 80. Sanofi Recent Development Table 81. Hayao Company Information Table 82. Hayao Business Overview Table 83. Hayao Sleeping Pills (Prescription Drugs) Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Hayao Sleeping Pills (Prescription Drugs) Product Portfolio Table 85. Hayao Recent Development Table 86. Cayman Chemical Company Information Table 87. Cayman Chemical Business Overview Table 88. Cayman Chemical Sleeping Pills (Prescription Drugs) Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Cayman Chemical Sleeping Pills (Prescription Drugs) Product Portfolio Table 90. Cayman Chemical Recent Development Table 91. Aurobindo Pharma Company Information Table 92. Aurobindo Pharma Business Overview Table 93. Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Aurobindo Pharma Sleeping Pills (Prescription Drugs) Product Portfolio Table 95. Aurobindo Pharma Recent Development Table 96. Apotex Company Information Table 97. Apotex Business Overview Table 98. Apotex Sleeping Pills (Prescription Drugs) Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Apotex Sleeping Pills (Prescription Drugs) Product Portfolio Table 100. Apotex Recent Development Table 101. Ambitropin Company Information Table 102. Ambitropin Business Overview Table 103. Ambitropin Sleeping Pills (Prescription Drugs) Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Ambitropin Sleeping Pills (Prescription Drugs) Product Portfolio Table 105. Ambitropin Recent Development Table 106. Allegiant Health Company Information Table 107. Allegiant Health Business Overview Table 108. Allegiant Health Sleeping Pills (Prescription Drugs) Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Allegiant Health Sleeping Pills (Prescription Drugs) Product Portfolio Table 110. Allegiant Health Recent Development Table 111. Actellon Pharmaceuticals Company Information Table 112. Actellon Pharmaceuticals Business Overview Table 113. Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Product Portfolio Table 115. Actellon Pharmaceuticals Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Sleeping Pills (Prescription Drugs) Distributors List Table 119. Sleeping Pills (Prescription Drugs) Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Sleeping Pills (Prescription Drugs) Product Image Figure 2. Global Sleeping Pills (Prescription Drugs) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sleeping Pills (Prescription Drugs) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sleeping Pills (Prescription Drugs) Sales (2021-2032) & (M Units) Figure 5. Global Sleeping Pills (Prescription Drugs) Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Sleeping Pills (Prescription Drugs) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Adapin (doxepin) Image Figure 10. Ativan (lorazepam) Image Figure 11. Ramelteon (Rozerem) Image Figure 12. Eszopiclone (Lunesta) Image Figure 13. Zolpidem Image Figure 14. Global Sleeping Pills (Prescription Drugs) Sales Volume by Type (2021 VS 2025 VS 2032) & (M Units) Figure 15. Global Sleeping Pills (Prescription Drugs) Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Sleeping Pills (Prescription Drugs) Sales Volume Share by Type (2021-2032) Figure 17. Global Sleeping Pills (Prescription Drugs) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Sleeping Pills (Prescription Drugs) Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Sleeping Pills (Prescription Drugs) Sales Value Share by Type (2021-2032) Figure 20. Hospital Pharmacy Image Figure 21. Retail Pharmacy Image Figure 22. Global Sleeping Pills (Prescription Drugs) Sales Volume by Application (2021 VS 2025 VS 2032) & (M Units) Figure 23. Global Sleeping Pills (Prescription Drugs) Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Sleeping Pills (Prescription Drugs) Sales Volume Share by Application (2021-2032) Figure 25. Global Sleeping Pills (Prescription Drugs) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Sleeping Pills (Prescription Drugs) Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Sleeping Pills (Prescription Drugs) Sales Value Share by Application (2021-2032) Figure 28. Global Sleeping Pills (Prescription Drugs) Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 29. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Sleeping Pills (Prescription Drugs) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Sleeping Pills (Prescription Drugs) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Sleeping Pills (Prescription Drugs) Sales Value (2021-2032) & (US$ Million) Figure 33. North America Sleeping Pills (Prescription Drugs) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Sleeping Pills (Prescription Drugs) Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Sleeping Pills (Prescription Drugs) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Sleeping Pills (Prescription Drugs) Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Sleeping Pills (Prescription Drugs) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Sleeping Pills (Prescription Drugs) Sales Value (2021-2032) & (US$ Million) Figure 39. South America Sleeping Pills (Prescription Drugs) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Sleeping Pills (Prescription Drugs) Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Sleeping Pills (Prescription Drugs) Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Sleeping Pills (Prescription Drugs) Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Sleeping Pills (Prescription Drugs) Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Adapin (doxepin)
  • Ativan (lorazepam)
  • Ramelteon (Rozerem)
  • Eszopiclone (Lunesta)
  • Zolpidem
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
Companies covered
  • Abbott Laboratories
  • Takeda Pharmaceutical
  • Sanofi
  • Hayao
  • Cayman Chemical
  • Aurobindo Pharma
  • Apotex
  • Ambitropin
  • Allegiant Health
  • Actellon Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sleeping Pills (Prescription Drugs) Sales Value (2021-2032)
  4. 1.2.2 Global Sleeping Pills (Prescription Drugs) Sales Volume (2021-2032)
  5. 1.2.3 Global Sleeping Pills (Prescription Drugs) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sleeping Pills (Prescription Drugs) Market Dynamics
  1. 2.1 Sleeping Pills (Prescription Drugs) Industry Trends
  2. 2.2 Sleeping Pills (Prescription Drugs) Industry Drivers
  3. 2.3 Sleeping Pills (Prescription Drugs) Industry Opportunities and Challenges
  4. 2.4 Sleeping Pills (Prescription Drugs) Industry Restraints
3 Sleeping Pills (Prescription Drugs) Market by Company
  1. 3.1 Global Sleeping Pills (Prescription Drugs) Company Revenue Ranking in 2025
  2. 3.2 Global Sleeping Pills (Prescription Drugs) Revenue by Company (2021-2026)
  3. 3.3 Global Sleeping Pills (Prescription Drugs) Sales Volume by Company (2021-2026)
  4. 3.4 Global Sleeping Pills (Prescription Drugs) Average Price by Company (2021-2026)
  5. 3.5 Global Sleeping Pills (Prescription Drugs) Company Ranking (2024-2026)
  6. 3.6 Global Sleeping Pills (Prescription Drugs) Company Manufacturing Base and Headquarters
  7. 3.7 Global Sleeping Pills (Prescription Drugs) Company Product Type and Application
  8. 3.8 Global Sleeping Pills (Prescription Drugs) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sleeping Pills (Prescription Drugs) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sleeping Pills (Prescription Drugs) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sleeping Pills (Prescription Drugs) Market by Type
  1. 4.1 Sleeping Pills (Prescription Drugs) Type Introduction
  2. 4.1.1 Adapin (doxepin)
  3. 4.1.2 Ativan (lorazepam)
  4. 4.1.3 Ramelteon (Rozerem)
  5. 4.1.4 Eszopiclone (Lunesta)
  6. 4.1.5 Zolpidem
  7. 4.2 Global Sleeping Pills (Prescription Drugs) Sales Volume by Type
  8. 4.2.1 Global Sleeping Pills (Prescription Drugs) Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Sleeping Pills (Prescription Drugs) Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Sleeping Pills (Prescription Drugs) Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Sleeping Pills (Prescription Drugs) Sales Value by Type
  12. 4.3.1 Global Sleeping Pills (Prescription Drugs) Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Sleeping Pills (Prescription Drugs) Sales Value by Type (2021-2032)
  14. 4.3.3 Global Sleeping Pills (Prescription Drugs) Sales Value Share by Type (2021-2032)
5 Sleeping Pills (Prescription Drugs) Market by Application
  1. 5.1 Sleeping Pills (Prescription Drugs) Application Introduction
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Retail Pharmacy
  4. 5.2 Global Sleeping Pills (Prescription Drugs) Sales Volume by Application
  5. 5.2.1 Global Sleeping Pills (Prescription Drugs) Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Sleeping Pills (Prescription Drugs) Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Sleeping Pills (Prescription Drugs) Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Sleeping Pills (Prescription Drugs) Sales Value by Application
  9. 5.3.1 Global Sleeping Pills (Prescription Drugs) Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Sleeping Pills (Prescription Drugs) Sales Value by Application (2021-2032)
  11. 5.3.3 Global Sleeping Pills (Prescription Drugs) Sales Value Share by Application (2021-2032)
6 Sleeping Pills (Prescription Drugs) Regional Sales and Value Analysis
  1. 6.1 Global Sleeping Pills (Prescription Drugs) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sleeping Pills (Prescription Drugs) Sales by Region (2021-2032)
  3. 6.2.1 Global Sleeping Pills (Prescription Drugs) Sales by Region: 2021-2026
  4. 6.2.2 Global Sleeping Pills (Prescription Drugs) Sales by Region (2027-2032)
  5. 6.3 Global Sleeping Pills (Prescription Drugs) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sleeping Pills (Prescription Drugs) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sleeping Pills (Prescription Drugs) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sleeping Pills (Prescription Drugs) Sales Value by Region (2027-2032)
  9. 6.5 Global Sleeping Pills (Prescription Drugs) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sleeping Pills (Prescription Drugs) Sales Value (2021-2032)
  12. 6.6.2 North America Sleeping Pills (Prescription Drugs) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sleeping Pills (Prescription Drugs) Sales Value (2021-2032)
  15. 6.7.2 Europe Sleeping Pills (Prescription Drugs) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sleeping Pills (Prescription Drugs) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sleeping Pills (Prescription Drugs) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sleeping Pills (Prescription Drugs) Sales Value (2021-2032)
  21. 6.9.2 South America Sleeping Pills (Prescription Drugs) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sleeping Pills (Prescription Drugs) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sleeping Pills (Prescription Drugs) Sales Value Share by Country, 2025 VS 2032
7 Sleeping Pills (Prescription Drugs) Country-level Sales and Value Analysis
  1. 7.1 Global Sleeping Pills (Prescription Drugs) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sleeping Pills (Prescription Drugs) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sleeping Pills (Prescription Drugs) Sales by Country (2021-2032)
  4. 7.3.1 Global Sleeping Pills (Prescription Drugs) Sales by Country (2021-2026)
  5. 7.3.2 Global Sleeping Pills (Prescription Drugs) Sales by Country (2027-2032)
  6. 7.4 Global Sleeping Pills (Prescription Drugs) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sleeping Pills (Prescription Drugs) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sleeping Pills (Prescription Drugs) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sleeping Pills (Prescription Drugs) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sleeping Pills (Prescription Drugs) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sleeping Pills (Prescription Drugs) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott Laboratories
  2. 8.1.1 Abbott Laboratories Company Information
  3. 8.1.2 Abbott Laboratories Business Overview
  4. 8.1.3 Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Laboratories Sleeping Pills (Prescription Drugs) Product Portfolio
  6. 8.1.5 Abbott Laboratories Recent Developments
  7. 8.2 Takeda Pharmaceutical
  8. 8.2.1 Takeda Pharmaceutical Company Information
  9. 8.2.2 Takeda Pharmaceutical Business Overview
  10. 8.2.3 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Product Portfolio
  12. 8.2.5 Takeda Pharmaceutical Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Sleeping Pills (Prescription Drugs) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Sleeping Pills (Prescription Drugs) Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Hayao
  20. 8.4.1 Hayao Company Information
  21. 8.4.2 Hayao Business Overview
  22. 8.4.3 Hayao Sleeping Pills (Prescription Drugs) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hayao Sleeping Pills (Prescription Drugs) Product Portfolio
  24. 8.4.5 Hayao Recent Developments
  25. 8.5 Cayman Chemical
  26. 8.5.1 Cayman Chemical Company Information
  27. 8.5.2 Cayman Chemical Business Overview
  28. 8.5.3 Cayman Chemical Sleeping Pills (Prescription Drugs) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Cayman Chemical Sleeping Pills (Prescription Drugs) Product Portfolio
  30. 8.5.5 Cayman Chemical Recent Developments
  31. 8.6 Aurobindo Pharma
  32. 8.6.1 Aurobindo Pharma Company Information
  33. 8.6.2 Aurobindo Pharma Business Overview
  34. 8.6.3 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Product Portfolio
  36. 8.6.5 Aurobindo Pharma Recent Developments
  37. 8.7 Apotex
  38. 8.7.1 Apotex Company Information
  39. 8.7.2 Apotex Business Overview
  40. 8.7.3 Apotex Sleeping Pills (Prescription Drugs) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Apotex Sleeping Pills (Prescription Drugs) Product Portfolio
  42. 8.7.5 Apotex Recent Developments
  43. 8.8 Ambitropin
  44. 8.8.1 Ambitropin Company Information
  45. 8.8.2 Ambitropin Business Overview
  46. 8.8.3 Ambitropin Sleeping Pills (Prescription Drugs) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Ambitropin Sleeping Pills (Prescription Drugs) Product Portfolio
  48. 8.8.5 Ambitropin Recent Developments
  49. 8.9 Allegiant Health
  50. 8.9.1 Allegiant Health Company Information
  51. 8.9.2 Allegiant Health Business Overview
  52. 8.9.3 Allegiant Health Sleeping Pills (Prescription Drugs) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Allegiant Health Sleeping Pills (Prescription Drugs) Product Portfolio
  54. 8.9.5 Allegiant Health Recent Developments
  55. 8.10 Actellon Pharmaceuticals
  56. 8.10.1 Actellon Pharmaceuticals Company Information
  57. 8.10.2 Actellon Pharmaceuticals Business Overview
  58. 8.10.3 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Product Portfolio
  60. 8.10.5 Actellon Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sleeping Pills (Prescription Drugs) Value Chain Analysis
  2. 9.1.1 Sleeping Pills (Prescription Drugs) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sleeping Pills (Prescription Drugs) Sales Mode & Process
  6. 9.2 Sleeping Pills (Prescription Drugs) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sleeping Pills (Prescription Drugs) Distributors
  9. 9.2.3 Sleeping Pills (Prescription Drugs) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst